{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:45:43Z","timestamp":1794620743427,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102606"],"award-info":[{"award-number":["82102606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Jiangsu Province","award":["BK20210093"],"award-info":[{"award-number":["BK20210093"]}]},{"name":"the Project of Science and Technology Development Plan of Suzhou","award":["SKJYD2021081"],"award-info":[{"award-number":["SKJYD2021081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accumulating evidence suggests that osteoclastogenesis and angiogenesis in subchondral bone are critical destructive factors in the initiation and progression of osteoarthritis (OA). Herein, methoxypolyethylene glycol amine (mPEG-NH<jats:sub>2<\/jats:sub>) modified polydopamine nanoparticles (PDA-PEG NPs) were synthesized for treating early OA. The cytotoxicity and reactive oxygen species (ROS) scavenging ability of PDA-PEG NPs were evaluated. The effects of PDA-PEG NPs on osteoclast differentiation and vessel formation were then evaluated. Further, PDA-PEG NPs were administrated to anterior cruciate ligament transection (ACLT)-induced OA mice. Results demonstrated that PDA-PEG NPs had low toxicity both in vitro and in vivo. PDA-PEG NPs could inhibit osteoclastogenesis via regulating nuclear factor kappa B (NF-\u03baB) and mitogen-activated protein kinase (MAPK) signaling pathways. Moreover, PDA-PEG NPs suppressed osteoclast-related angiogenesis via down-regulating platelet-derived growth factor-BB (PDGF-BB). In vivo, PDA-PEG NPs inhibited subchondral bone resorption and angiogenesis, further rescuing cartilage degradation in OA mice. In conclusion, we demonstrated that PDA-PEG NPs deployment could be a potential therapy for OA.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-022-01697-y","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T22:02:41Z","timestamp":1668636161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Antioxidant PDA-PEG nanoparticles alleviate early osteoarthritis by inhibiting osteoclastogenesis and angiogenesis in subchondral bone"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhikai","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong Jiong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"9","key":"1697_CR1","first-page":"1461","volume":"56","author":"T H\u00fcgle","year":"2017","unstructured":"H\u00fcgle T, Geurts J. What drives osteoarthritis?-synovial versus subchondral bone pathology. Rheumatology (Oxford). 2017;56(9):1461\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"1697_CR2","doi-asserted-by":"publisher","first-page":"16028","DOI":"10.1038\/boneres.2016.28","volume":"4","author":"DM Findlay","year":"2016","unstructured":"Findlay DM, Kuliwaba JS. Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res. 2016;4:16028.","journal-title":"Bone Res"},{"key":"1697_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jot.2018.03.001","volume":"14","author":"R Daugaard","year":"2018","unstructured":"Daugaard R, Tjur M, Sliepen M, et al. Are patients with knee osteoarthritis and patients with knee joint replacement as physically active as healthy persons? J Orthop Translat. 2018;14:8\u201315.","journal-title":"J Orthop Translat"},{"key":"1697_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/1874325001206010558","volume":"6","author":"UG Longo","year":"2012","unstructured":"Longo UG, Loppini M, Fumo C, et al. Osteoarthritis: new insights in animal models. Open Orthop J. 2012;6:558\u201363.","journal-title":"Open Orthop J"},{"issue":"3","key":"1697_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363\u201388.","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1586\/17474124.2016.1142872","volume":"10","author":"L Melcarne","year":"2016","unstructured":"Melcarne L, Garcia-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2016;10(6):723\u201333.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9783","key":"1697_CR7","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115\u201326.","journal-title":"Lancet"},{"issue":"10","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/annrheumdis-2018-214940","volume":"78","author":"X Zhu","year":"2019","unstructured":"Zhu X, Chen F, Lu K, et al. PPAR\u03b3 preservation via promoter demethylation alleviates osteoarthritis in mice. Ann Rheum Dis. 2019;78(10):1420\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1697_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33\u201342.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1697_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrrheum.2016.148","volume":"12","author":"SR Goldring","year":"2016","unstructured":"Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016;12(11):632\u201344.","journal-title":"Nat Rev Rheumatol"},{"key":"1697_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2018.00269","volume":"9","author":"W Mu","year":"2018","unstructured":"Mu W, Xu B, Ma H, et al. Halofuginone attenuates osteoarthritis by rescuing bone remodeling in subchondral bone through oral gavage. Front Pharmacol. 2018;9:269.","journal-title":"Front Pharmacol"},{"key":"1697_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.biopha.2017.10.018","volume":"96","author":"C Zhao","year":"2017","unstructured":"Zhao C, Liu Q, Wang K. Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis. Biomed Pharmacother. 2017;96:410\u20136.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1697_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrrheum.2012.130","volume":"8","author":"DB Burr","year":"2012","unstructured":"Burr DB, Gallant MA. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012;8(11):665\u201373.","journal-title":"Nat Rev Rheumatol"},{"key":"1697_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bone.2014.06.009","volume":"66","author":"M Siebelt","year":"2014","unstructured":"Siebelt M, Waarsing JH, Groen HC, et al. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression. Bone. 2014;66:163\u201370.","journal-title":"Bone"},{"issue":"4","key":"1697_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.joca.2009.12.006","volume":"18","author":"PI Mapp","year":"2010","unstructured":"Mapp PI, Walsh DA, Bowyer J, Maciewicz RA. Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthr Cartil. 2010;18(4):593\u2013600.","journal-title":"Osteoarthr Cartil"},{"key":"1697_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","volume":"6","author":"Y Han","year":"2018","unstructured":"Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res. 2018;6:16.","journal-title":"Bone Res"},{"issue":"11","key":"1697_CR17","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/nm.3668","volume":"20","author":"H Xie","year":"2014","unstructured":"Xie H, Cui Z, Wang L, et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014;20(11):1270\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"1697_CR18","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/annrheumdis-2015-207923","volume":"75","author":"Z Cui","year":"2016","unstructured":"Cui Z, Crane J, Xie H, et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-beta activity and H-type vessel formation in subchondral bone. Ann Rheum Dis. 2016;75(9):1714\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1697_CR19","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.joca.2015.06.020","volume":"23","author":"C Shen","year":"2015","unstructured":"Shen C, Cai GQ, Peng JP, Chen XD. Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS\/Akt\/FOXO3 signaling. Osteoarthritis Cartilage. 2015;23(12):2279\u201387.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"1697_CR20","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1074\/jbc.R111.271999","volume":"287","author":"T Finkel","year":"2012","unstructured":"Finkel T. Signal transduction by mitochondrial oxidants. J Biol Chem. 2012;287(7):4434\u201340.","journal-title":"J Biol Chem"},{"issue":"1","key":"1697_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201102095","volume":"194","author":"T Finkel","year":"2011","unstructured":"Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194(1):7\u201315.","journal-title":"J Cell Biol"},{"issue":"6","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1111\/jcmm.14333","volume":"23","author":"F Zhou","year":"2019","unstructured":"Zhou F, Mei J, Yuan K, et al. Isorhamnetin attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes through modulating reactive oxygen species homeostasis. J Cell Mol Med. 2019;23(6):4395\u2013407.","journal-title":"J Cell Mol Med"},{"issue":"45","key":"1697_CR23","doi-asserted-by":"publisher","first-page":"e2102485","DOI":"10.1002\/smll.202102485","volume":"17","author":"T Wang","year":"2021","unstructured":"Wang T, Fan Q, Hong J, et al. Therapeutic nanoparticles from grape seed for modulating oxidative stress. Small. 2021;17(45):e2102485.","journal-title":"Small"},{"issue":"14","key":"1697_CR24","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1039\/D1CS00374G","volume":"50","author":"P Yang","year":"2021","unstructured":"Yang P, Zhu F, Zhang Z, et al. Stimuli-responsive polydopamine-based smart materials. Chem Soc Rev. 2021;50(14):8319\u201343.","journal-title":"Chem Soc Rev"},{"issue":"9","key":"1697_CR25","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/cr400407a","volume":"114","author":"Y Liu","year":"2014","unstructured":"Liu Y, Ai K, Lu L. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem Rev. 2014;114(9):5057\u2013115.","journal-title":"Chem Rev"},{"issue":"7","key":"1697_CR26","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1039\/D0CS00908C","volume":"50","author":"D Wu","year":"2021","unstructured":"Wu D, Zhou J, Creyer MN, et al. Phenolic-enabled nanotechnology: versatile particle engineering for biomedicine. Chem Soc Rev. 2021;50(7):4432\u201383.","journal-title":"Chem Soc Rev"},{"issue":"15","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1039\/C8NR00838H","volume":"10","author":"H Zhao","year":"2018","unstructured":"Zhao H, Zeng Z, Liu L, et al. Polydopamine nanoparticles for the treatment of acute inflammation-induced injury. Nanoscale. 2018;10(15):6981\u201391.","journal-title":"Nanoscale"},{"issue":"2","key":"1697_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.31635\/ccschem.020.201900077","volume":"2","author":"P Yang","year":"2020","unstructured":"Yang P, Gu Z, Zhu F, Li Y. Structural and functional tailoring of melanin-like polydopamine radical scavengers. CCS Chem. 2020;2(2):128\u201338.","journal-title":"CCS Chem"},{"issue":"9","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1021\/acsnano.8b04022","volume":"12","author":"X Bao","year":"2018","unstructured":"Bao X, Zhao J, Sun J, Hu M, Yang X. Polydopamine nanoparticles as efficient scavengers for reactive oxygen species in periodontal disease. ACS Nano. 2018;12(9):8882\u201392.","journal-title":"ACS Nano"},{"issue":"7","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acs.accounts.0c00150","volume":"53","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lin Z, Ju Y, et al. Polyphenol-mediated assembly for particle engineering. Acc Chem Res. 2020;53(7):1269\u201378.","journal-title":"Acc Chem Res"},{"key":"1697_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fphar.2019.00270","volume":"10","author":"N Gao","year":"2019","unstructured":"Gao N, Xing C, Wang H, et al. pH-Responsive dual drug-loaded nanocarriers based on poly (2-ethyl-2-oxazoline) modified black phosphorus nanosheets for cancer chemo\/photothermal therapy. Front Pharmacol. 2019;10:270.","journal-title":"Front Pharmacol"},{"issue":"18","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"13470","DOI":"10.1039\/C4RA16469E","volume":"5","author":"H Luo","year":"2015","unstructured":"Luo H, Gu C, Zheng W, et al. Facile synthesis of novel size-controlled antibacterial hybrid spheres using silver nanoparticles loaded with poly-dopamine spheres. RSC Adv. 2015;5(18):13470\u20137.","journal-title":"RSC Adv"},{"issue":"7","key":"1697_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7150\/thno.14431","volume":"6","author":"Z Dong","year":"2016","unstructured":"Dong Z, Gong H, Gao M, et al. Polydopamine nanoparticles as a versatile molecular loading platform to enable imaging-guided cancer combination therapy. Theranostics. 2016;6(7):1031\u201342.","journal-title":"Theranostics"},{"issue":"6937","key":"1697_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u201342.","journal-title":"Nature"},{"issue":"12","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.4049\/jimmunol.1000885","volume":"185","author":"K Kim","year":"2010","unstructured":"Kim K, Kim JH, Youn BU, Jin HM, Kim N. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-kappaB activation and NFATc1 induction. J Immunol. 2010;185(12):7460\u20136.","journal-title":"J Immunol"},{"key":"1697_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fphar.2018.00174","volume":"9","author":"Z Hu","year":"2018","unstructured":"Hu Z, Chen Y, Song L, et al. Flavopiridol protects bone tissue by attenuating RANKL induced osteoclast formation. Front Pharmacol. 2018;9:174.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1697_CR37","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1039\/C7DT04080F","volume":"47","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang F, Wang Q, et al. The synthesis of LA-Fe3O4@PDA-PEG-DOX for photothermal therapy-chemotherapy. Dalton Trans. 2018;47(7):2435\u201343.","journal-title":"Dalton Trans"},{"issue":"1","key":"1697_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1573397117666211006094117","volume":"18","author":"L Molfetta","year":"2022","unstructured":"Molfetta L, Casabella A, Rosini S, Saviola G, Palermo A. Role of the osteochondral unit in the pathogenesis of osteoarthritis: focus on the potential use of clodronate. Curr Rheumatol Rev. 2022;18(1):2\u201311.","journal-title":"Curr Rheumatol Rev"},{"key":"1697_CR39","doi-asserted-by":"publisher","first-page":"101249","DOI":"10.1016\/j.arr.2020.101249","volume":"66","author":"L Zheng","year":"2021","unstructured":"Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66:101249.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1697_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"1697_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.joca.2011.01.021","volume":"19","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Bednis K, Stanaitis I. Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthr Cartil. 2011;19(4):366\u201374.","journal-title":"Osteoarthr Cartil"},{"issue":"3","key":"1697_CR42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bioactmat.2020.04.008","volume":"5","author":"T Zhu","year":"2020","unstructured":"Zhu T, Cui Y, Zhang M, et al. Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis. Bioact Mater. 2020;5(3):584\u2013601.","journal-title":"Bioact Mater"},{"issue":"2","key":"1697_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bioactmat.2020.08.016","volume":"6","author":"D Zhao","year":"2021","unstructured":"Zhao D, Zhu T, Li J, et al. Poly(lactic-co-glycolic acid)-based composite bone-substitute materials. Bioact Mater. 2021;6(2):346\u201360.","journal-title":"Bioact Mater"},{"key":"1697_CR44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.bioactmat.2021.08.005","volume":"9","author":"T Zhu","year":"2022","unstructured":"Zhu T, Jiang M, Zhang M, et al. Biofunctionalized composite scaffold to potentiate osteoconduction, angiogenesis, and favorable metabolic microenvironment for osteonecrosis therapy. Bioact Mater. 2022;9:446\u201360.","journal-title":"Bioact Mater"},{"issue":"4","key":"1697_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00167-010-1054-z","volume":"18","author":"H Madry","year":"2010","unstructured":"Madry H, van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):419\u201333.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"10","key":"1697_CR46","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.joca.2011.07.003","volume":"19","author":"M Bellido","year":"2011","unstructured":"Bellido M, Lugo L, Roman-Blas JA, et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. Osteoarthr Cartil. 2011;19(10):1228\u201336.","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"1697_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrrheum.2013.113","volume":"9","author":"G Herrero-Beaumont","year":"2013","unstructured":"Herrero-Beaumont G, Roman-Blas JA. Osteoarthritis. Osteoporotic OA: a reasonable target for bone-acting agents. Nat Rev Rheumatol. 2013;9(8):448\u201350.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1697_CR48","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/annrheumdis-2017-212364","volume":"77","author":"WF Lems","year":"2018","unstructured":"Lems WF. Bisphosphonates: a therapeutic option for knee osteoarthritis? Ann Rheum Dis. 2018;77(9):1247\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1\u20132","key":"1697_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-014-2187-z","volume":"397","author":"KN Reed","year":"2014","unstructured":"Reed KN, Wilson G, Pearsall A, Grishko VI. The role of mitochondrial reactive oxygen species in cartilage matrix destruction. Mol Cell Biochem. 2014;397(1\u20132):195\u2013201.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"1697_CR50","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"NK Lee","year":"2005","unstructured":"Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 2005;106(3):852\u20139.","journal-title":"Blood"},{"issue":"9","key":"1697_CR51","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","volume":"24","author":"Y Abu-Amer","year":"2013","unstructured":"Abu-Amer Y. NF-kappaB signaling and bone resorption. Osteoporos Int. 2013;24(9):2377\u201386.","journal-title":"Osteoporos Int"},{"issue":"10","key":"1697_CR52","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.7150\/ijbs.12296","volume":"11","author":"X Kong","year":"2015","unstructured":"Kong X, Yang Y, Wu W, et al. Triterpenoid saponin W3 from anemone flaccida suppresses osteoclast differentiation through inhibiting activation of MAPKs and NF-kappaB pathways. Int J Biol Sci. 2015;11(10):1204\u201314.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"1697_CR53","doi-asserted-by":"publisher","first-page":"e23199","DOI":"10.1371\/journal.pone.0023199","volume":"6","author":"H Tao","year":"2011","unstructured":"Tao H, Okamoto M, Nishikawa M, Yoshikawa H, Myoui A. P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. PLoS ONE. 2011;6(8):e23199.","journal-title":"PLoS ONE"},{"issue":"6","key":"1697_CR54","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1021\/acs.jnatprod.7b00927","volume":"81","author":"W Lee","year":"2018","unstructured":"Lee W, Ko KR, Kim HK, et al. Dehydrodiconiferyl alcohol inhibits osteoclast differentiation and ovariectomy-induced bone loss through acting as an estrogen receptor agonist. J Nat Prod. 2018;81(6):1343\u201356.","journal-title":"J Nat Prod"},{"issue":"14","key":"1697_CR55","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.febslet.2009.06.047","volume":"583","author":"I Song","year":"2009","unstructured":"Song I, Kim JH, Kim K, et al. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett. 2009;583(14):2435\u201340.","journal-title":"FEBS Lett"},{"key":"1697_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.02.006","volume":"83","author":"K Jodko-Piorecka","year":"2015","unstructured":"Jodko-Piorecka K, Litwinienko G. Antioxidant activity of dopamine and L-DOPA in lipid micelles and their cooperation with an analogue of alpha-tocopherol. Free Radic Biol Med. 2015;83:1\u201311.","journal-title":"Free Radic Biol Med"},{"key":"1697_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2474-9-20","volume":"9","author":"YH Sniekers","year":"2008","unstructured":"Sniekers YH, Intema F, Lafeber FP, et al. A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord. 2008;9:20.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"1697_CR58","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"SS Glasson","year":"2007","unstructured":"Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthritis Cartilage. 2007;15(9):1061\u20139.","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"1697_CR59","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00264-020-04926-x","volume":"45","author":"S Shanmugasundaram","year":"2021","unstructured":"Shanmugasundaram S, Vaish A, Chavada V, Murrell WD, Vaishya R. Assessment of safety and efficacy of intra-articular injection of stromal vascular fraction for the treatment of knee osteoarthritis-a systematic review. Int Orthop. 2021;45(3):615\u201325.","journal-title":"Int Orthop"},{"issue":"6","key":"1697_CR60","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1038\/s41418-020-00731-6","volume":"28","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zhang X, Huang B, et al. Site-1 protease controls osteoclastogenesis by mediating LC3 transcription. Cell Death Differ. 2021;28(6):2001\u201318.","journal-title":"Cell Death Differ"},{"issue":"7","key":"1697_CR61","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/ijms22073380","volume":"22","author":"IG Munteanu","year":"2021","unstructured":"Munteanu IG, Apetrei C. Analytical methods used in determining antioxidant activity: a review. Int J Mol Sci. 2021;22(7):3380.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1697_CR62","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1021\/acsomega.1c00755","volume":"6","author":"GS Hemlata","year":"2021","unstructured":"Hemlata GS, Tejavath KK. ROS-mediated apoptosis induced by BSA nanospheres encapsulated with fruit extract of cucumis prophetarum in various human cancer cell lines. ACS Omega. 2021;6(15):10383\u201395.","journal-title":"ACS Omega"},{"key":"1697_CR63","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.biopha.2017.09.011","volume":"95","author":"M Liu","year":"2017","unstructured":"Liu M, Zhong S, Kong R, et al. Paeonol alleviates interleukin-1beta-induced inflammatory responses in chondrocytes during osteoarthritis. Biomed Pharmacother. 2017;95:914\u201321.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1697_CR64","doi-asserted-by":"publisher","first-page":"7310","DOI":"10.1002\/jcb.27028","volume":"119","author":"J Han","year":"2018","unstructured":"Han J, Gao W, Su D, Liu Y. Gypenoside inhibits RANKL-induced osteoclastogenesis by regulating NF-kappaB, AKT, and MAPK signaling pathways. J Cell Biochem. 2018;119(9):7310\u20138.","journal-title":"J Cell Biochem"},{"key":"1697_CR65","doi-asserted-by":"publisher","first-page":"108140","DOI":"10.1016\/j.diabres.2020.108140","volume":"165","author":"TY Wang","year":"2020","unstructured":"Wang TY, Wang W, Li FF, et al. Maggot excretions\/secretions promote diabetic wound angiogenesis via miR18a\/19a -TSP-1 axis. Diabetes Res Clin Pract. 2020;165:108140.","journal-title":"Diabetes Res Clin Pract"},{"key":"1697_CR66","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-4939-1215-5_23","volume":"1194","author":"J Lorenz","year":"2014","unstructured":"Lorenz J, Grassel S. Experimental osteoarthritis models in mice. Methods Mol Biol. 2014;1194:401\u201319.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1697_CR67","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bone.2012.03.025","volume":"50","author":"T Hayami","year":"2012","unstructured":"Hayami T, Zhuo Y, Wesolowski GA, Pickarski M, Duong LT. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone. 2012;50(6):1250\u20139.","journal-title":"Bone"},{"key":"1697_CR68","doi-asserted-by":"publisher","first-page":"e2094","DOI":"10.1038\/cddis.2016.11","volume":"7","author":"H Qiao","year":"2016","unstructured":"Qiao H, Wang TY, Yu ZF, et al. Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK\/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model. Cell Death Dis. 2016;7:e2094.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1697_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KP Pritzker","year":"2006","unstructured":"Pritzker KP, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil. 2006;14(1):13\u201329.","journal-title":"Osteoarthr Cartil"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01697-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T11:14:19Z","timestamp":1668770059000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01697-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"20 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments and tests were guided and approved by the Ethics Committee of the First Affiliated Hospital of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare in relation to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}